Related Experiment Video
Updated: Jun 13, 2025
06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
14.8K
Drug therapies for stroke prevention.
Nimisha Shaji1, Robert F Storey2, William A E Parker3
1Final Year Medical Student.
The British Journal of Cardiology
|September 9, 2024
Summary
Stroke prevention involves managing risk factors like atrial fibrillation with oral anticoagulation and atherosclerotic cardiovascular diseases with antiplatelet therapy. Comprehensive assessment and treatment are key to reducing stroke incidence and its impact.
Area of Science:
- Neurology
- Cardiology
- Preventive Medicine
Background:
- Stroke is a leading cause of death, disability, and economic burden.
- Understanding different stroke types (thrombotic, embolic, hemorrhagic) is crucial for effective prevention.
- Key risk factors include atrial fibrillation, atherosclerotic cardiovascular diseases, hypertension, dyslipidemia, and diabetes.
Purpose of the Study:
- To outline comprehensive strategies for stroke prevention.
- To emphasize the importance of risk factor modification.
Main Methods:
- Review of current guidelines and evidence for stroke prevention therapies.
- Discussion of pharmacological interventions including oral anticoagulation and antiplatelet therapy.
- Highlighting the role of blood pressure, lipid, and glycemic control.
Main Results:
- Oral anticoagulation is recommended for patients with atrial fibrillation/flutter.
- Antiplatelet therapy is indicated for patients with established atherosclerotic cardiovascular diseases.
- Intensified antiplatelet therapy or combined therapy can further reduce ischemic stroke risk but increases bleeding risk.
- Blood pressure, lipid, and glycemic control are essential.
- Inflammation is an emerging target for stroke prevention.
Conclusions:
- Comprehensive assessment and pharmacological management of risk factors are central to stroke prevention.
- Tailoring therapies based on stroke type and patient risk factors is critical.
- Ongoing research into novel targets like inflammation may offer future prevention strategies.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398